Section Arrow
SPRC.NASDAQ
- SciSparc Ltd
(Financial Status)
Quotes are at least 15-min delayed:2024/12/24 13:01 EST
Last
 0.2212
-0.0116 (-4.98%)
Day High 
0.2423 
Prev. Close
0.2328 
1-M High
0.2849 
Volume 
313.75K 
Bid
0.2156
Ask
0.2276
Day Low
0.216 
Open
0.2416 
1-M Low
0.197 
Market Cap 
2.41M 
Currency USD 
P/E
%Yield -- 
10-SMA 0.24 
20-SMA 0.23 
50-SMA 0.24 
52-W High 6.78 
52-W Low 0.197 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.28/--
Enterprise Value
2.44M
Balance Sheet
Book Value Per Share
0.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.88M
Operating Revenue Per Share
0.32
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3815-0.0216-5.36%-- 
CMNDClearmind Medicine1.68+0.46+37.70%0.16PE
CEROCERo Therapeutics Holdings0.0609+0.0104+20.59%-- 
RXRXRecursion Pharmaceuticals7.2401+0.2501+3.58%-- 
CDTConduit Pharmaceuticals0.0577+0.0032+5.87%-- 
Quotes are at least 15-min delayed:2024/12/24 13:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.